Global Sepsis Diagnostics Market to Grow at 8.9% During 2023-2028, Propelled by Rising Cases of Hospital-Acquired Infections

April 18, 2022 | Healthcare

The latest report by IMARC Group, titled “Sepsis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” finds that the global sepsis diagnostics market is expected to exhibit a CAGR of 8.9% during 2023-2028. Sepsis diagnostics involve the use of various laboratory tests and medical techniques to diagnose sepsis, a critical life-threatening condition caused by the body’s response to bacterial, fungal, viral, or parasitic infections. If left untreated, sepsis can lead to a systemic inflammatory reaction, formation of blood clots, and eventually organ dysfunction or failure. Some commonly used sepsis diagnostic methods include molecular diagnosis, immunoassays, microfluidics, biomarkers, flow cytometry, polymerase chain reaction (PCR), and sequencing. As a result, sepsis diagnostics find extensive applications across hospitals, clinics, pathology and reference laboratories, and academic research institutes for early diagnosis and effective treatment of sepsis.


Global Sepsis Diagnostics Market Trends:

The rising cases of hospital-acquired infections (HAI) and infectious diseases that can trigger sepsis, especially among the elderly, infants and individuals suffering from chronic conditions, represent the primary factors driving the market growth. Besides this, the recent outbreak of coronavirus disease (COVID-19) and surging hospital admission rates have resulted in a subsequent increase in the risk of developing sepsis, thereby escalating the demand for sepsis diagnostics. Additionally, the widespread adoption of advanced data analytics tools that enable the integration of multiple test results from different platforms to offer real-time data access and accurate disease diagnosis has propelled the market growth. Furthermore, several key players are making heavy investments in research and development (R&D) projects focused on new blood culture approaches to identify and treat chronic infections. In line with this, technological advancements, such as the introduction of novel immunological and molecular biomarkers that facilitate the early detection of sepsis, have accelerated the product adoption rate. Other factors, including the launch of technologically advanced diagnostic methods, significant growth in the healthcare sector, increasing penetration of molecular diagnostic technology, rising regulatory approvals, and supportive government initiatives, are also creating a favorable market outlook.


Market Summary:

  • Based on the diagnosis, the market has been bifurcated into automated and conventional diagnostics. 
  • The market has been segregated based on the product into instruments, assay kits and reagents, blood culture media, and software. 
  • On the basis of the mode of testing, the market has been classified as laboratory and point-of-care tests. 
  • Based on technology, the market has been categorized into molecular diagnostics, immunoassays, biomarkers, flow cytometry, microfluidics, and blood culture. 
  • The market has been divided based on the pathogen into bacterial (gram-positive and gram-negative bacterial sepsis), viral, fungal, and other sepsis.
  • On the basis of the end user, the market has been segmented into diagnostic clinics, hospitals, and research laboratories. 
  • Region-wise, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, and others), Asia Pacific (China, India, Japan, Australia, Singapore, and others), Latin America (Brazil, Mexico, Argentina, and others), and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, and others). 
  • The competitive landscape of the market has also been analyzed, with some of the key players being Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc.


Report Scope:

Report Features Details
Base Year of the Analysis 2022
Historical Period 2017-2022
Forecast Period 2023-2028
Units US$ Million
Segment Coverage Diagnosis, Product, Mode of Testing, Technology, Pathogen, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, Australia, Singapore, Brazil, Mexico, Argentina, Saudi Arabia, United Arab Emirates, South Africa
Companies Covered Abbott Laboratories, Becton, Dickinson and Company (BD), biomerieux SA, Bruker Corporation, EKF Diagnostics Holding Plc, Epic Systems Corporation, Luminex Corporation, Roche Holding AG, Sysmex Corporation, and T2 Biosystems Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, and nanotechnology industries. We also provide cost model and manufacturing setup project reports through Syndicated Analytics, a subsidiary of IMARC Group.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Sepsis Diagnostics Market to Grow at 8.9% During 2023-2028, Propelled by Rising Cases of Hospital-Acquired Infections
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More